MICROMET

Welcome to the Brand page for “MICROMET”, which is offered here for Medicines for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, b cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, b cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; preparations for diagnosis and analysis of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material for medical or veterinary purposes; biological preparations in the nature of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides for medical purposes; sanitary preparations for medical purposes, particularly agents for dental care;color is not claimed as a feature of the mark.;chemical preparations for scientific purposes excluding chemical preparations for the treatment of water; chemical agents for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides; biochemical preparations, eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides for scientific purposes;scientific and industrial research, particularly in the field of molecular biology, biotechnology, genetics, medicine, pharmacology and cell biology; identification of target structures for the development of medicaments, identifications of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; developments of technologies and means for scientific and industrial research, particularly of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; providing of technology, technology consultation, for scientific and industrial research; performance of chemical, biological and scientific diagnoses and analyses of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides for scientific purposes;.

Its status is currently believed to be active. Its class is unavailable. “MICROMET” is believed to be currently owned by “MICROMET AG”.